# Cerebrovascular Reserve Measurements in Sickle Cell Disease

> **NCT02824406** · — · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 60 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Acetazolamide

## Key facts

- **NCT ID:** NCT02824406
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2017-06
- **Final completion:** 2017-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02824406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02824406, "Cerebrovascular Reserve Measurements in Sickle Cell Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02824406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*